U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX24323869: GSM8219068: CTRL HiC rep2; human gammaherpesvirus 4; Hi-C
1 ILLUMINA (Illumina HiSeq 2500) run: 133.2M spots, 16.9G bases, 5Gb downloads

External Id: GSM8219068_r1
Submitted by: Brigham and Women's Hospital
Study: The chromatin loop release factor WAPL regulates EBV latency status by restricting LMP production
show Abstracthide Abstract
Epstein-Barr virus (EBV) is a ubiquitous human pathogen that is etiologically linked to several cancers and has been connected to multiple sclerosis. EBV employs a series of latency programs, including latency III, latency II, and latency I, to persistently colonize the B-cell compartment. Each of these programs is associated with human malignancies. However, our understanding remains incomplete of how these distinct latency programs are epigenetically restricted. While regulation of the chromatin structure of the EBV genome by cohesin and CTCF contributes to genome regulation, the function of the cohesin release factor Wings Apart-Like Protein Homolog (WAPL) had not previously been understood. In this study, we employ RNA-seq combined with immunofluorescence analysis to determine that loss of WAPL leads to aberrant expression of the oncogenic latent membrane proteins LMP1 and LMP2A in latency I Burkitt lymphoma cells. Through a combination of Hi-C, Hi-ChIP, and ChIP-qPCR, we uncover that WAPL loss causes alterations in looping across the EBV genome and specifically induces formation of loops between the LMP promoter and the oriLyt enhancers. We propose that EBV coopts WAPL to maintain a strict latency I state and, without WAPL, leaky expression of the LMP proteins occurs. Overall design: HiC sequencing of EBV genome in WAPL WT and KO cell lines
Sample: CTRL HiC rep2
SAMN41031582 • SRS21085249 • All experiments • All runs
Library:
Name: GSM8219068
Instrument: Illumina HiSeq 2500
Strategy: Hi-C
Source: GENOMIC
Selection: other
Layout: PAIRED
Construction protocol: Libraries of total ligation products were produced using Ultralow Library Systems V2 as per manufacturer's protocol. Purified libraries were then enriched for only EBV genome ligation products using myBaits enrichment kit as per manufacturer's protocol.
Runs: 1 run, 133.2M spots, 16.9G bases, 5Gb
Run# of Spots# of BasesSizePublished
SRR28758386133,170,98016.9G5Gb2024-08-07

ID:
32637420

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...